Skip to content

Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study-

Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study- - Suppressive effect of combination of test food on the postprandial triglyceride level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032752
Enrollment
50
Registered
2018-05-29
Start date
2018-06-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Sponsors

FANCL Corporation Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Males and females 20 to 64 years of age. 2)Subjects whose fasting serum triglyceride levels are less than 200 mg/dL.

Exclusion criteria

Exclusion criteria: 1)Subjects who has serious medical history or who had digestive tract resection surgery. 2)Subjects who routinely use medicine, supplements, FOSHU and/or health food which affect to result of the study. 3)Subjects who have allergy to the test food or high fat meal and have extreme lactose intolerance or diarrhea. 4)Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating. 5) Heavy use of alcohol or excessive smokers 6) Subjects who is considered to be inappropriate to attend the present study by the investigator.

Design outcomes

Primary

MeasureTime frame
Area under the curve for postprandial serum triglyceride level

Secondary

MeasureTime frame
Area under the curve for Remnant-like particle cholesterol, and serum triglyceride levels and Remnant-like particle cholesterol of before, 2, 3, 4 and 6 hours after high fat meal ingestion.

Countries

Japan

Contacts

Public ContactKosuke Suzuki

Medical Corporation Jikokai Clinical Trial Division

suzuki-jikoukai@e-mail.jp011-868-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026